AMSTERDAM, the Netherlands -- Embolization of large spontaneous portosystemic shunts can relieve refractory hepatic encephalopathy and can keep many patients free of it for the long term as long as ...

February 20, 2007 — The US Food and Drug Administration (FDA) has approved a vascular shunt for temporarily restoring blood flow to severely injured limbs, a molecular test to assess the risk for ...

MANCHESTER, England, April 28  Spontaneous cerebral blood clots appear to be a common pathology of Alzheimer's disease and vascular dementia, and they may be targets for prevention or treatment ...

The U.S. Food and Drug Administration (FDA) today cleared for U.S. marketing a vascular shunt, a medical device that can help save the arms and legs of soldiers critically injured in combat as well as ...

Pulmonary vascular function is impaired with increased pulmonary blood flow (PBF). We hypothesized that a peroxisome proliferator–activated receptor-γ (PPAR-γ) agonist would mitigate this effect. An ...

ATLANTA, GA—The implantation of a Ventura (V-Wave) interatrial shunt failed to improve prognosis or reduce symptoms across a wide range of patients with heart failure (HF), results from a new ...

Of six patients with diffuse glomerulonephritis and associated infected ventriculoatrial shunt, three had improved renal function after removal of the infected shunt, and three died from ...

Acquired SEPS are associated with portal hypertension, cirrhosis, and complications of decompensation. In particular, the effects of NVEPS on portal pressure are variable, but there is evidence of ...

Heart failure with preserved ejection fraction (HFpEF) can arise from a range of genetic and physiological triggers, but the common denominator—elevated left atrial (LA) pressure—has spawned a host of ...